newsfilter
← Latest News
Business Wire·

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period

Bristol Myers Squibb (NYSE:BMY) and RayzeBio, Inc. (NASDAQ:RYZB) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, in connection with